CANCER CHEMOTHERAPY AND PHARMACOLOGY, vol.72, no.2, pp.437-444, 2013 (SCI-Expanded)
This study was conducted to determine the clinical significance of serum M30 and M65 in epithelial ovarian cancer (EOC).